AA
GRCL

AlphaCentric Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

AlphaCentric Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,000
Closed -$236K – 282
2021
Q3 		$236K Buy
+17,000
New +$236K 0.06% 105
2021
Q2 		– Sell
-19,000
Closed -$293K – 246
2021
Q1 		$293K Buy
+19,000
New +$293K 0.1% 75